Jártasság helyi Ráközelíteni overall survival common bile duct cancer Kilenc követelmények nyugtalanító
Cholangiocarcinoma - Bile Duct Cancer - Causes, Symptoms, Treatment
Comparison of the overall-survival rates between hilar... | Download Scientific Diagram
Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence | BMC Gastroenterology | Full Text
Cholangiocarcinoma - Wikipedia
Current Oncology | Free Full-Text | A Population-Based Retrospective Study of Biliary Tract Cancers in Alberta, Canada
Bile Duct Cancer (Cholangiocarcinoma) Treatment (PDQ®)–Health Professional Version - NCI
Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology
Tumour Budding as an Independent Prognostic Factor for Survival in Patients With Distal Bile Duct Cancer | Anticancer Research
Frontiers | The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer
The new insight of treatment in Cholangiocarcinoma
Distinct prognosis of biliary tract cancer according to tumor location, stage, and treatment: a population-based study | Scientific Reports
Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma
Comparison of the overall-survival rates between hilar... | Download Scientific Diagram
Cancers | Free Full-Text | Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options
Biliary tract cancers: NCDB role in rare malignancy | The Bulletin
A) Disease-free survival curve of 122 patients with distal bile duct... | Download Scientific Diagram
Durvalumab Improves Survival in Bile Duct Cancers - NCI
Predictive factors of early recurrence after R0 resection of hilar cholangiocarcinoma: A single institution experience in China - Hu - 2019 - Cancer Medicine - Wiley Online Library
Clinicopathological analysis and prognosis of extrahepatic bile duct cancer with a microscopic positive ductal margin - ScienceDirect
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer | NEJM Evidence
Cholangiocarcinoma - "Klatskin's" Tumors of the Bile Duct System - CancerConnect
Biliary tract cancers: NCDB role in rare malignancy | The Bulletin
Medicines | Free Full-Text | PARP Inhibitors in Biliary Tract Cancer: A New Kid on the Block?
Comparison of the recurrence-free survival rates between hilar... | Download Scientific Diagram